{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:37:22Z","timestamp":1784173042884,"version":"3.55.0"},"reference-count":12,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>Twenty\u2010six children with B\u2010cell acute lymphoblastic leukaemia (B\u2010ALL) or Murphy Stage III or IV B\u2010cell non\u2010Hodgkin's lymphoma (B\u2010NHL) progressed or relapsed after first\u2010line therapy with a short, intensive multiagent chemotherapy regimen [United Kingdom Childhood Cancer Study Group (UKCCSG) 9003] (<jats:italic>n<\/jats:italic>\u2003=\u200362) or a slightly less intensive regimen (UKCCSG 9002) (<jats:italic>n<\/jats:italic>\u2003=\u2003112). Eight patients (4\u00b76%) never achieved complete remission (CR) and 18 (10\u00b73%) relapsed. Second\u2010line therapy resulted in remission for eight patients (30%). All patients initially treated with the 9003 protocol died. Three patients (11\u00b75%) in the 9002 group, including one who never achieved CR in the primary site, are alive after second\u2010line therapy. This study confirms that the prognosis of relapsed or refractory B\u2010ALL\/B\u2010NHL is poor and exceptionally so if relapse occurred less than 6\u2003months from diagnosis. High\u2010dose therapy with stem cell rescue was used in only seven patients; its role needs to be studied further.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02647.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:32:45Z","timestamp":1047364365000},"page":"965-968","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Outcome of relapsed or refractory childhood B\u2010cell acute lymphoblastic leukaemia and B\u2010cell non\u2010Hodgkin's lymphoma treated with the UKCCSG 9003\/9002 protocols"],"prefix":"10.1111","volume":"112","author":[{"given":"A.","family":"Atra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gerrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Imeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. M.","family":"Hann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. R.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.379"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1083"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1252"},{"key":"e_1_2_5_5_1","first-page":"29","article-title":"Disseminated non\u2010lymphoblastic non\u2010Hodgkin's lymphoma (DNLHL) of childhood: a randomised phase II trial of short intensive treatment (abstract 093)","volume":"7","author":"Cairo M.","year":"1996","journal-title":"Annals of Oncology"},{"key":"e_1_2_5_6_1","first-page":"183","article-title":"High\u2010dose etoposide and cisplatin in refractory or recurrent non\u2010Hodgkin's lymphoma (NHL)","volume":"32","author":"Colombat P.","year":"1990","journal-title":"Nouvelle-Revue-Francaise-d'Hematologie"},{"key":"e_1_2_5_7_1","first-page":"551","article-title":"14 relapses out of 225 children from the SFOP non\u2010Hodgkin's B lymphoma LMB\u201089 (abstract 80)","volume":"21","author":"Frappaz D.","year":"1993","journal-title":"Medical Pediatric Oncology"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.4.661"},{"key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V81.9.2263.2263","article-title":"Adjuvant immunotoxin therapy with anti\u2010B4\u2010blocked ricin after autologous bone marrow\u00a0transplantation for patients with B\u2010cell non\u2010Hodgkin's lymphoma","volume":"81","author":"Grossbard M.L.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.1.123"},{"key":"e_1_2_5_11_1","first-page":"218","article-title":"Outcome of relapsed childhood B\u2010cell lymphoma (BCL) after intensive first line treatment (Tt): the experience of the French Society of Pediatric Oncology (SFOP) in the LMB89 protocol. (abstract 104)","volume":"33","author":"Patte C.","year":"1999","journal-title":"Medical Pediatric Oncology"},{"key":"e_1_2_5_12_1","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V81.8.2003.2003","article-title":"Curability of relapsed childhood B\u2010cell non\u2010Hodgkin's lymphoma after intensive first line therapy: a report from the Societe Francaise de Oncologie Pediatrique","volume":"81","author":"Philip T.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.359"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02647.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02647.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02647.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T16:09:59Z","timestamp":1695830999000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02647.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02647.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02647.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}